Gilead’s $1.5B in remdesivir sales help buoy worse-than-expected declines for mainstay HIV, hepatitis C drugs April 30, 2021 Auto Bot News 0 Gilead’s $1.5B in remdesivir sales help buoy worse-than-expected declines for mainstay HIV, hepatitis C drugs nhigginsdunn Fri, 04/30/2021 – 08:10
